Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1293300 Target Snapshot

Diphosphomevalonate decarboxylase · SINGLE PROTEIN · Streptococcus pneumoniae serotype 2 (strain D39 / NCTC 7466)

28Compounds
1Assays
0Approved Drugs
28.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9FD53. Use UniProt Q9FD53 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9FD53 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Diphosphomevalonate decarboxylase as ChEMBL target CHEMBL1293300, mapped to UniProt Q9FD53. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Diphosphomevalonate decarboxylase
SINGLE PROTEIN · Streptococcus pneumoniae serotype 2 (strain D39 / NCTC 7466)
As of 2026-09-14
ChEMBL target ID
CHEMBL1293300
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9FD53
diphosphomevalonate decarboxylase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Diphosphomevalonate decarboxylase is the right protein anchor across sources, using UniProt Q9FD53 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Labeldiphosphomevalonate decarboxylase
UniProt AccessionQ9FD53
Component TypeProtein
Sequence Length317 aa

diphosphomevalonate decarboxylase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Diphosphomevalonate decarboxylase, mapped to UniProt Q9FD53. ChEMBL maps the protein component as diphosphomevalonate decarboxylase. Sequence length is 317 aa.

Mapped IDQ9FD53
Review nameDiphosphomevalonate decarboxylase
OrganismStreptococcus pneumoniae serotype 2 (strain D39 / NCTC 7466)
Assay Mix

Activity Type Distribution

IC5028.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1316078 5.38 IC50 4150.0 Preclinical
CHEMBL1394251 5.33 IC50 4680.0 Preclinical
CHEMBL1411202 5.32 IC50 4740.0 Preclinical
CHEMBL1435753 5.13 IC50 7480.0 Preclinical
CHEMBL1551379 5.12 IC50 7640.0 Preclinical
CHEMBL1475475 5.06 IC50 8660.0 Preclinical
CHEMBL1394263 5.0 IC50 9980.0 Preclinical
CHEMBL1512600 4.98 IC50 10500.0 Preclinical
CHEMBL1317006 4.94 IC50 11400.0 Preclinical
CHEMBL1434101 4.92 IC50 11900.0 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
0
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

1
Total Assays
28
Tested Compounds
1
Assay Types
Functional — 1 assays, 28 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 28 4.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine